The incidence and risk for suicidality and self-harm were low for individuals given glucagon-like peptide-1 receptor agonists ...

Popular weight-loss drugs like Ozempic (generic name: semaglutide), which are intended for people with type 2 diabetes and also known as GLP-1 agonist drugs, may be beneficial for brain health, but ...

TUESDAY, March 11, 2025 (HealthDay News) -- Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize risks for complications, ...

Blockbuster GLP-1 medications like Ozempic and Wegovy are transforming patient care, altering surgery volumes and redefining the healthcare industry's financial landscape. Beyond weight loss ...

In recent years, GLP-1 for weight loss has emerged as a significant breakthrough, capturing the attention of both healthcare providers and individuals struggling with obesity. Glucagon-like peptide-1 ...

Kidney stones are among the possible risks of GLP-1 use that were not previously known. Glucagon-like peptide 1 receptor agonists (GLP-1RAs) may have a wider range of benefits and risks than what the ...

Cardano (ADA) price displays weakness on March 11 ... BTC price has since recovered above $81,000 but is still down 1.3% over the last 24 hours. Ether (ETH) has also dropped by 8.6% over the ...

This article is part of a featured content programme.

Novo Nordisk (NVO) stock was down more than 8% Monday morning after the Danish drugmaker shared new data on its next-generation GLP-1 drug, CagriSema. The drug, a mix of cagrilintide and ...

Cardano (ADA) is experiencing a notable price increase, with projections suggesting it may reach $1.20 within the next week. This surge is partly attributed to Grayscale’s recent application for a ...

“Originally, GLP-1 was connected to diabetics and blood sugar control. People using these products won’t have the same sugar craving as before, so they’ll be having the salty snack in small ...

Consequently, the ADA price surged from $0.64 to around $1.10, reinforcing the positive Cardano price prediction from late 2024. However, analysts like Anthony Pompliano have questioned Trump’s plans ...